INSIGHTS ON QUALITY ASSURANCE

• Automating Cell Therapy Manufacturing Without Redesigning Workflows

  Cell therapy manufacturing teams face mounting pressure to automate without disrupting workflows. Learn how incremental automation can preserve process integrity and reduce risk.

• Denaturing SEC-MS Analysis Of High Molecular Weight Impurities

  Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.

• The Commercial Advantage Of Softgels

  Among oral dosage forms, softgel capsules stand out as a versatile and high-performance option — offering superior delivery characteristics, consumer appeal, and brand differentiation.

• Improving Accuracy In Size Measurements Of Nanomedicine

  Precise particle sizing is key to formulation success. Advanced analytics overcome DLS limitations, providing reliable data that reduces risk and supports long-term product stability.

• Increasing The Sustainability Of API Production

  9/24/2026

  From green chemistry to digital tools, see how process optimization is helping pharmaceutical manufacturers meet sustainability goals and improve operations.

• Manufacturing Readiness: Why Compliance Is Won Or Lost On The Floor

  8/6/2026

  Achieve continuous regulatory readiness by embedding ALCOA++ compliance directly into manufacturing workflows to eliminate paper-based documentation risks.

• Intact- And Peptide-Level Characterization Of T-DM1 In Vitro

  6/18/2026

  A sensitive workflow that combines affinity capture and high-resolution mass spectrometry reveals how antibody-drug conjugates evolve under physiological conditions, offering deeper insight into their stability.

• Cambrex Scientist Spotlight: Luigi Bellone

  1/29/2025

  Luigi Bellone, Head of Quality Assurance in Paullo, Milan, brings over 20 years of experience in quality assurance (QA), quality control (QC), and regulatory compliance within the pharmaceutical industry.

• Visibility For BioPharma Operation: From Data Insights To Better Outcomes

  10/16/2026

  Handoffs between development, scheduling, execution, and quality are where speed is won or lost. The open question is how much context survives each one.